Abstract Title:

Role of toll-like receptor 4 in melatonin-induced cardioprotection.

Abstract Source:

J Pineal Res. 2015 Oct 14. Epub 2015 Oct 14. PMID: 26465095

Abstract Author(s):

Frederic Nduhirabandi, Kim Lamont, Zulfah Albertyn, Lionel H Opie, Sandrine Lecour

Article Affiliation:

Frederic Nduhirabandi


Melatonin protects the heart against myocardial ischemia/reperfusion injury via the activation of the Survivor Activating Factor Enhancement (SAFE) pathway which involves tumor necrosis factor alpha (TNFα) and the signal transducer and activator of transcription 3 (STAT3). Toll-like receptor 4 (TLR4) plays a crucial role in myocardial ischemia/reperfusion injury and activates TNFα. In the present study, we investigated whether melatonin may target TLR4 to activate the SAFE pathway. Isolated hearts from rats or mice were subjected to ischemia/reperfusion injury. Melatonin (75ng/L) or/and TAK242 (a specific inhibitor of TLR4 signaling, 500 nM) were administered to the rat hearts before the induction of ischemia. Pre-ischemic myocardial STAT3 was evaluated by western blotting. Lipopolysaccharide (LPS, a stimulator of TLR4) was administered to wild type, TNFα receptor 2 knockout or cardiomyocyte-specific STAT3-deficient mice (2.8 mg/kg, i.p) 45 min before the heart isolation. Myocardial infarct size was measured as an end-point. Compared to the control, administration of melatonin reduced myocardial infarct size (34.7±2.8% versus 62.6±2.7%, p<0.01). This protective effect was abolished in the presence of TAK242 (49.2±6.5%). Melatonin administered alone increased the pre-ischemic activation of mitochondrial STAT3 and this effect was attenuated with TAK242. Furthermore, stimulation of TLR4 with LPS pre-treatment to mice reduced myocardial infarct size of the hearts isolated from wild type animals but failed to protect the hearts isolated from TNFα receptor 2 knockout or cardiomyocyte-specific STAT3-deficient mice (p<0.001). Taken together, these data suggest that cardioprotection induced by melatonin is mediated by TLR4 to activate the SAFE pathway. This article is protected by copyright. All rights reserved.

Study Type : Animal Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.